Furthermore, unlike malignant transformation, in which Sall4 loss impairs HC-to-CCA oncogenic reprogramming, its loss in cholestatic injury promotes HC transition into LPCs (co-expressing HNF4A and SOX9). The gene discussed is SALL4; the disease is cholangiocarcinoma.